For the quarter ending 2026-03-31, AVNS made $182,200K in revenue. $5,100K in net income. Net profit margin of 2.80%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net sales | 182,200 | 180,900 | 177,800 | 175,000 |
| Cost of products sold | 88,000 | 94,900 | 91,800 | 82,900 |
| Gross profit | 94,200 | 86,000 | 86,000 | 92,100 |
| Research and development | 5,200 | 6,100 | 6,000 | 5,800 |
| Selling and general expenses | 77,700 | 78,800 | 77,600 | 83,500 |
| Goodwill impairment | - | - | 0 | 77,000 |
| Goodwill and intangibles impairment | - | 0 | - | - |
| Other expense (income), net | -2,400 | 1,400 | -2,300 | -300 |
| Operating income | 8,900 | 2,500 | 100 | -74,500 |
| Interest income | 200 | 600 | 500 | 600 |
| Interest expense | 1,500 | 1,900 | 1,800 | 2,000 |
| Income before income taxes | 7,600 | 1,200 | -1,200 | -75,900 |
| Income tax provision | 2,500 | 2,500 | 200 | 900 |
| Loss from continuing operations | - | -1,300 | -1,400 | -76,800 |
| Loss from discontinued operations, net of tax | - | 0 | 0 | 0 |
| Net income | 5,100 | -1,300 | -1,400 | -76,800 |
| Basic EPS | 0.11 | -0.028 | -0.03 | -1.66 |
| Diluted EPS | 0.11 | -0.028 | -0.03 | -1.66 |
| Basic Average Shares | 46,500,000 | 46,400,000 | 46,400,000 | 46,300,000 |
| Diluted Average Shares | 47,500,000 | 45,700,000 | 46,400,000 | 46,300,000 |
AVANOS MEDICAL, INC. (AVNS)
AVANOS MEDICAL, INC. (AVNS)